2-201726434-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_020919.4(ALS2):c.3248+50G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0169 in 1,468,126 control chromosomes in the GnomAD database, including 267 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 24 hom., cov: 32)
Exomes 𝑓: 0.017 ( 243 hom. )
Consequence
ALS2
NM_020919.4 intron
NM_020919.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.106
Publications
1 publications found
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
ALS2 Gene-Disease associations (from GenCC):
- ALS2-related motor neuron diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- amyotrophic lateral sclerosis type 2, juvenileInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- infantile-onset ascending hereditary spastic paralysisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
- juvenile primary lateral sclerosisInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
- juvenile amyotrophic lateral sclerosisInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 2-201726434-C-T is Benign according to our data. Variant chr2-201726434-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 261373.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0136 (2066/152260) while in subpopulation NFE AF = 0.0184 (1252/68024). AF 95% confidence interval is 0.0176. There are 24 homozygotes in GnomAd4. There are 1034 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 24 AR gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ALS2 | NM_020919.4 | c.3248+50G>A | intron_variant | Intron 19 of 33 | ENST00000264276.11 | NP_065970.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ALS2 | ENST00000264276.11 | c.3248+50G>A | intron_variant | Intron 19 of 33 | 1 | NM_020919.4 | ENSP00000264276.6 |
Frequencies
GnomAD3 genomes AF: 0.0136 AC: 2069AN: 152142Hom.: 25 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2069
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0156 AC: 3871AN: 248548 AF XY: 0.0158 show subpopulations
GnomAD2 exomes
AF:
AC:
3871
AN:
248548
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0172 AC: 22693AN: 1315866Hom.: 243 Cov.: 20 AF XY: 0.0171 AC XY: 11336AN XY: 662728 show subpopulations
GnomAD4 exome
AF:
AC:
22693
AN:
1315866
Hom.:
Cov.:
20
AF XY:
AC XY:
11336
AN XY:
662728
show subpopulations
African (AFR)
AF:
AC:
98
AN:
30412
American (AMR)
AF:
AC:
410
AN:
44512
Ashkenazi Jewish (ASJ)
AF:
AC:
988
AN:
25310
East Asian (EAS)
AF:
AC:
1
AN:
38958
South Asian (SAS)
AF:
AC:
420
AN:
83198
European-Finnish (FIN)
AF:
AC:
1254
AN:
52704
Middle Eastern (MID)
AF:
AC:
150
AN:
5532
European-Non Finnish (NFE)
AF:
AC:
18476
AN:
979726
Other (OTH)
AF:
AC:
896
AN:
55514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1215
2429
3644
4858
6073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
630
1260
1890
2520
3150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0136 AC: 2066AN: 152260Hom.: 24 Cov.: 32 AF XY: 0.0139 AC XY: 1034AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
2066
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
1034
AN XY:
74452
show subpopulations
African (AFR)
AF:
AC:
158
AN:
41522
American (AMR)
AF:
AC:
158
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
129
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5188
South Asian (SAS)
AF:
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
AC:
229
AN:
10618
Middle Eastern (MID)
AF:
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1252
AN:
68024
Other (OTH)
AF:
AC:
26
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
101
203
304
406
507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.